APSR2026-320

 
Late-Breaking
Submitted
Oral Presentation
AO28-002
 
 
https://storage.unitedwebnetwork.com/files/1285/1218305-46903-APSR2026_433615.pptx
Format: PPTX Only
 
Format: PDF Only
09. Asthma
6

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Ken Arimura * Tokyo Women’s Medical University Department of Respiratory Medicine Tokyo Japan
Keiko Kan-o - Tokyo Women’s Medical University Department of Respiratory Medicine Tokyo Japan
Yasuto Sato - National Institute of Public Health Center for Health Informatics Policy Saitama Japan
Ken Kikuchi - Tokyo Women’s Medical University Department of Infectious Diseases Tokyo Japan
Mitsuko Kondo - Tokyo Women’s Medical University Department of Respiratory Medicine Tokyo Japan
Etsuko Tagaya - Tokyo Women’s Medical University Department of Respiratory Medicine Tokyo Japan
 
 
 
 
 
 
 
 
 
Presenting Author Details
Ken
Arimura
arimuraken@gmail.com
+819035094126
41-50
Japan
Original Research
Clinical Significance in hMPV or RSV Co-infection With Other Respiratory Pathogens
Maximum 25 words
Abstract Content
Respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) are common causes of respiratory infection. Although co-infection with other respiratory pathogens is frequently observed, the clinical significance of this remains unclear.
We conducted a retrospective analysis of 57,746 patients who underwent comprehensive multiplex polymerase chain reaction testing with the FILMARRAY®. We compared clinical features between single and co-infections involving RSV or hMPV using chi-square or Fisher's exact tests. Multiple logistic regression was performed to identify associations with bronchial asthma (BA) exacerbation, adjusting for age, sex, testing period, and RSV co-infection.
Among patients with respiratory syncytial virus (RSV), co-infection was associated with a higher prevalence of a history of bronchial asthma (BA), wheezing, BA exacerbation, a combined history of BA and exacerbation, systemic steroid use, and an age under six years, compared to single infection. Co-infection with RSV and coronaviruses, parainfluenzas, adenoviruses, and rhinoviruses/enteroviruses was particularly associated with BA exacerbation. Using multiple logistic regression, age under 6 years and RSV co-infection were identified as independent risk factors for BA exacerbation. In contrast, no such associations were observed in hMPV co-infection.
Co-infection with RSV and other respiratory viruses increases the risk of bronchiolitis exacerbation, especially in patients under the age of six. Since the RSV vaccine for adults and the monoclonal antibody for high-risk children have been proven effective in preventing RSV-related lower respiratory tract disease, RSV-targeted prevention strategies appear to be effective in reducing the burden of respiratory disease in younger children.
 
 
 
 
 
No
No
 
JPG or JPEG or PNG format ONLY
BA exacerbation, hMPV co-infection, RSV co-infection
maximum 3 keywords and no abbreviations, separated by commas
This content was published in Lung 2025.
242